Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence

BACKGROUND: Methamphetamine-abuse is a worldwide health problem for which no effective therapy is available. Inhibition of methamphetamine-induced transporter-mediated dopamine (DA) release could be a useful approach to treat methamphetamine-addiction. We assessed the potencies of bupropion, methylp...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmler, Linda D, Wandeler, Rebecca, Liechti, Matthias E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679734/
https://www.ncbi.nlm.nih.gov/pubmed/23734766
http://dx.doi.org/10.1186/1756-0500-6-220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679734/
https://www.ncbi.nlm.nih.gov/pubmed/23734766
http://dx.doi.org/10.1186/1756-0500-6-220

Ejemplares similares